(AIMT) - Earnings & Price History

AIMT: - 28.845, $1.48B, -0.23 (-0.77%)

Sector: Healthcare - Industry: Biotechnology

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. The company was founded in 2011 and is headquartered in Brisbane, California.Key Statistics

Past AIMT reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-15AMC-0.4722.0622.6722.6221.8722.62-0.22%-2.48%-2.69%318.90K
2017-03-01AMC-0.472121.0420.9720.7121.5-0.33%0.14%-0.19%199.28K
2016-11-04AMC-0.46
2016-11-03AMC-0.4617.9316.4717.517.2618.256.25%▲2.46%8.86%544.14K
2016-11-02AMC-0.4616.4716.4316.514.8716.510.43%▲-0.18%0.24%133.21K
2016-03-03AMC-0.3517.717.8817.416.5818.12-2.68%1.72%-1.01%296.75K

Login | Register
Monday Dec 10, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades